CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation
Authors
Sally Arai
Xiaoyu Chai
+19Â more
George L. Chen
Mary E.D. Flowers
Michael Green
Teresa S. Hyun
Yoshihiro Inamoto
Madan H. Jagasia
Samantha Jaglowski
Nandita Khera
Stephanie J. Lee
Paul J. Martin
Sebastian A. Mayer
David B. Miklos
Jeanne Palmer
Joseph Pidala
Iskra Pusic
Stefanie Sarantopoulos
Howard M. Shulman
Barry E. Storer
William A. Wood
Publication date
1 January 2016
Publisher
Doi
Cite
View
on
PubMed
Abstract
Cutaneous sclerosis (CS) occurs in 20% of patients with chronic graft-versus-host disease (GVHD) and can compromise mobility and quality of life
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
DukeSpace
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:dukespace.lib.duke.edu:101...
Last time updated on 18/08/2016
Carolina Digital Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
cdr.lib.unc.edu:gm80j110r
Last time updated on 23/04/2020